Resultats de la cerca - Dalia Wajsbrot
- Mostrar 1 - 9 resultats de 9
-
1
An epidemiological study to assess the prevalence of diabetic peripheral neuropathic pain among adults with diabetes attending private and institutional outpatient clinics in South... per Andrew Jacovides, Mampedi Bogoshi, Larry A. Distiller, Ehab Mahgoub, Mahomed KA Omar, Ismail A Tarek, Dalia Wajsbrot
Publicat 2014Artigo -
2
Efficacy and safety of parecoxib in the treatment of acute renal colic: a randomized clinical trial per Sidney Glina, Ronaldo Damião, João Afif‐Abdo, Carlos Francisco Santa Maria, Raúl Novoa, Carlos Eurico Dornelles Cairoli, Dalia Wajsbrot, Gaston Araya
Publicat 2011Artigo -
3
Prevalence of Painful Diabetic Peripheral Neuropathy among Patients with Diabetes Mellitus in the Middle East Region per S Jambart, Z Ammache, Fares Haddad, Ahmed M. Younes, Ahmed Hassoun, Kamal Omer Abdalla, Carla Abou Selwan, Nancy Sunna, Dalia Wajsbrot, Ehab Youseif
Publicat 2011Artigo -
4
Safety and Efficacy of Ceftazidime–Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Con... per John S. Bradley, Emmanuel Roilides, Helen Broadhurst, Karen Cheng, Li‐Min Huang, Veronica MasCasullo, Paul Newell, Gregory G. Stone, Margaret Tawadrous, Dalia Wajsbrot, Katrina Yates, Annie Gardner
Publicat 2019Artigo -
5
Radioterapia em adenocarcinoma de pâncreas per Eduardo Weltman, João Víctor Salvajoli, Rodrigo de Morais Hanriot, Flávio Eduardo Prisco, Satiro De Oliveira, José Carlos da Cruz, Sandra Regina de Oliveira Borges, Mônica Lagatta, Dalia Wajsbrot
Publicat 2002Artigo -
6
Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to <18 Years With Complicated Intra-Abdominal Infection: Results From a Ph... per John S. Bradley, Helen Broadhurst, Karen Cheng, Maria José González, Paul Newell, Martin Prchlík, Gregory G. Stone, Angela K. Talley, Margaret Tawadrous, Dalia Wajsbrot, Katrina Yates, Antonina Zuzova, Annie Gardner
Publicat 2019Artigo -
7
Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the <scp>ALLEGRO</scp> phase 2b/3 randomized, double‐blind, placebo‐controlled trial per Maria Hordinsky, Adelaide A. Hebert, Melinda Gooderham, Ohsang Kwon, Nikolay N. Murashkin, Hong Fang, Kazutoshi Harada, Ernest H. Law, Dalia Wajsbrot, Liza Takiya, Samuel H. Zwillich, Robert Wołk, Helen Tran
Publicat 2023Artigo -
8
Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the <scp>ALLEGRO</scp> clinical development programme per Brett King, Paradi Mirmirani, Kristen Lo Sicco, Yuval Ramot, Rodney Sinclair, Leila Asfour, Khaled Ezzedine, C. Paul, M. Ohyama, Roger Edwards, Gianluca Bonfanti, U. Kerkmann, Dalia Wajsbrot, R. Ishowo‐Adejumo, Samuel H. Zwillich, A. Lejeune
Publicat 2025Artigo -
9
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial per Brett King, Xingqi Zhang, Walter Gubelin Harcha, Jacek C. Szepietowski, Jerry Shapiro, Charles Lynde, Natasha Atanaskova Mesinkovska, Samuel H. Zwillich, Lynne Napatalung, Dalia Wajsbrot, Rana Fayyad, Amy Freyman, Debanjali Mitra, Vivek S. Purohit, Rodney Sinclair, Robert Wołk
Publicat 2023Artigo
Eines de cerca:
Matèries relacionades
Internal medicine
Medicine
Surgery
Adverse effect
Pathology
Randomized controlled trial
Alopecia areata
Alternative medicine
Anesthesia
Dermatology
Gastroenterology
Hair loss
Placebo
Avibactam
Bacteria
Biology
Ceftazidime
Ceftazidime/avibactam
Clinical endpoint
Diabetes mellitus
Endocrinology
Genetics
Odds ratio
Outpatient clinic
Pseudomonas aeruginosa
Scalp
Type 2 diabetes
Adenocarcinoma
Adjuvant chemotherapy
Adjuvant radiotherapy